Adopted Trials - Lymphoma (NHL)
Acronym: R-CODOX-M/IVAC
Full Title
A phase II single arm study of the use of CODOX-M/IVAC with Rituximab (R-CODOX-M/IVAC) in the treatment of patients with Diffuse Large B-Cell Lymphoma (DLBCL) (Age-Adjusted International Prognostic Index (IPI) High or High-Intermediate Risk)
Treatment: Simple antibodies (indirect & direct acting)
Phase: 2
Current status: Open to recruitment
Chief Investigator: Dr Andrew McMillan
Type of trial: Early Phase
Website:
Acronym: R-GCVP
Full Title
A phase II multicentre trial of CVP, rituximan and gemcitabine for the treatment of patients with newly diagnosed diffuse large B-Cell lymphoma considered unsuitable for R-Chop chemotherapy
Treatment: Chemotherapy
Phase: 2
Current status: Open to recruitment
Chief Investigator: Dr Paul Fields
Type of trial: Early Phase
Website:
Acronym: GemBex
Full Title
A phase II study of Gemcitabine and Bexarotene (GemBex) in the treatment of cutaneous T-cell lymphoma
Treatment: Chemotherapy
Phase: 2
Current status: Open to recruitment
Chief Investigator: Prof Tim Illidge
Type of trial: Early Phase
Website:
Acronym: CHOP Velcade
Full Title
A parallel randomised phase II trial of CHOP chemotherapy with or without Bortezomib In Relapsed Mantle Cell Lymphoma
Treatment: Chemotherapy
Phase: 2
Current status: Open to recruitment
Chief Investigator: Dr Simon Rule
Type of trial: Early Phase
Website:
Acronym: PACIFICO
Full Title
Phase III multicentre trial comparing two different Purine-Alkylator Combination In Follicular lymphoma Immuno-Chemotherapy for Older patients (PACIFICO)
Treatment: Chemotherapy
Phase: 3
Current status: Open to recruitment
Chief Investigator: Prof Andrew Pettitt
Type of trial: Biomarkers
Website:
Acronym: SPRINT (MCL-002)
Full Title
A phase 2, multicentre, randomised open-label study to determine the efficacy of lenalidomide (Revlimid) versus investigator's choice in patients with relapsed or refractory mantle cell lymphoma.
Treatment: Chemotherapy
Phase: 2
Current status: In set-up
Chief Investigator: Dr Simon Rule
Type of trial: Early Phase
Website:
Acronym: ITCL
Full Title
A phase II evaluation of high dose chemotherapy and autologous stem cell transplantation for intestinal T-cell lymphomas.
Treatment: Other (please specify in Notes)
Phase: 2
Current status: On hold
Chief Investigator: Dr Anne Lennard
Type of trial: Early Phase
Website:
Acronym: AITL
Full Title
Phase ll Trial of Fludarabine & Cyclophosphamide followed by Thalidomide for Angioimmunoblastic Lymphoma
Treatment: Other complex biological therapies
Phase: 2
Current status: On hold
Chief Investigator: Dr Caludius Rudin
Type of trial: Early Phase
Website:
